跳至主要内容
临床试验/NCT00516308
NCT00516308终止2 期

A Non-Randomized Study of the NightHawk Peripheral Plaque Excision System During Plaque Excision of Peripheral Arterial Disease

FoxHollow Technologies2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2007年8月1日最近更新:
适应症

试验速览

阶段
2 期
状态
终止
发起方
入组人数
100
试验地点
2

研究概览

简要总结

To assess the proximity of the catheter to the vessel wall and to correlate excised tissue with images collected by the integrated Optical coherence Tomography (OCT) imaging system. The primary endpoints are correlation between OCT images and histological characterization of excised tissue.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Patient requires treatment for peripheral arterial disease (PAD).
  • Patient is willing and able to provide Informed Consent.
  • Patient has at least one focal, de novo infrainguinal lesion in a native vessel.
  • The minimum reference vessel diameter is 2.0 - 4.5 mm, dependent on the NightHawk device used.
  • The lesion is ≥ 50% stenosed by quantitative vascular angiography.
  • The lesion is ≤ 7 cm in length.
  • The patient must be able to take at least one form of anti-platelet or anti-thrombotic therapy.

排除标准

  • Patient presents with degree of limb disease or a co-existing medical condition that makes revascularization inappropriate.
  • The patient has diffuse peripheral arterial disease and/or the disease is heavily calcified.
  • Patient presents with concomitant disease contraindicating an endovascular intervention.
  • Patient is pregnant.
  • The patient has a hypersensitivity to contrast materials that cannot be adequately pretreated.

研究者

发起方
FoxHollow Technologies
申办方类型
Industry

研究点 (2)

Loading locations...

相似试验